AINDEX
Markets

InMode Ltd. (INMD)

INMDNASDAQ-GSBiotechnology: Electromedical & Electrotherapeutic Apparatus

$13.25

+0.0400 (+0.30%) today

Closed, Nov 13, 4:00 PM ET

+0.30% 1D
Market cap
$762.77m
P/E
–
EPS, last 4 quarters
–
Dividend yield
–
Day range
–
52-week range
$12.72 to $16.67
Average volume
–
Previous close
$13.21

Analysts

2 covering

Hold0 buy, 2 hold, 0 sell

Targets a year out average $15.00, +13.2% from here

$15.00now $13.25$15.00

Earnings

Next report

Financials

QuarterMar 2019
Revenue$30.55m
Gross profit$26.28m
Operating income$9.93m
Net income$10.12m

News

8 latest

The company

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ('RF') technology. InMode strives to enable emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology.

Sector
Health Care
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Exchange
NASDAQ-GS
Region
Middle East

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.